ProShare Advisors
ELVN icon

ProShare Advisors’s Enliven Therapeutics ELVN Stock Holding History

ProShare Advisors’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,125
Closed -$199K – 2111
2025
Q1 		$199K Sell
10,125
-2,104
-17% -$41.4K ﹤0.01% 1689
2024
Q4 		$275K Buy
12,229
+2,788
+30% +$62.7K ﹤0.01% 1695
2024
Q3 		$241K Buy
+9,441
New +$241K ﹤0.01% 1615